Search research articles
Contact Us
Filters
Showing results (71-80 of 153) with videos related to
Page
of 16
Sort By:
Cancers
|
July 20, 2019
Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma
Viola J Chen, Gabriela Hernandez-Meza, Prashasti Agrawal, et al.
Urologic Oncology
|
June 29, 2020
Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer
Hriday P Bhambhvani, Alvaro Zamora, Eugene Shkolyar, et al.
The American Journal of Surgical Pathology
|
April 28, 2025
Renal Epithelioid Angiomyolipoma: Prognostic Implications of Targeted Immunohistochemical and Molecular Markers in Conjunction with Clinicopathologic Features
Ankur R Sangoi, Anandi Lobo, Shilpy Jha, et al.
European Urology
|
March 8, 2016
Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable?
Philip V Barbosa, I-Chun Thomas, Sandy Srinivas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2013
NCCN Task Force Report: Bone Health In Cancer Care
Julie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2007
Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer
Ronald M Bukowski, Fairooz F Kabbinavar, Robert A Figlin, et al.
The Oncologist
|
July 22, 2024
A review of mitotane in the management of adrenocortical cancer
Jaydira Del Rivero, Tobias Else, Julie Hallanger-Johnson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2011
NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy
Gary R Hudes, Michael A Carducci, Toni K Choueiri, et al.
European Urology
|
April 18, 2017
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma
Sumanta K Pal, Guru Sonpavde, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN Task Force Report: Bone Health in Cancer Care
Julie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 153) with videos related to
Sort By:
Page
of 16
Cancers
|
July 20, 2019
Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma
Viola J Chen, Gabriela Hernandez-Meza, Prashasti Agrawal, et al.
Urologic Oncology
|
June 29, 2020
Development of robust artificial neural networks for prediction of 5-year survival in bladder cancer
Hriday P Bhambhvani, Alvaro Zamora, Eugene Shkolyar, et al.
The American Journal of Surgical Pathology
|
April 28, 2025
Renal Epithelioid Angiomyolipoma: Prognostic Implications of Targeted Immunohistochemical and Molecular Markers in Conjunction with Clinicopathologic Features
Ankur R Sangoi, Anandi Lobo, Shilpy Jha, et al.
European Urology
|
March 8, 2016
Overall Survival in Patients with Localized Prostate Cancer in the US Veterans Health Administration: Is PIVOT Generalizable?
Philip V Barbosa, I-Chun Thomas, Sandy Srinivas, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2013
NCCN Task Force Report: Bone Health In Cancer Care
Julie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2007
Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer
Ronald M Bukowski, Fairooz F Kabbinavar, Robert A Figlin, et al.
The Oncologist
|
July 22, 2024
A review of mitotane in the management of adrenocortical cancer
Jaydira Del Rivero, Tobias Else, Julie Hallanger-Johnson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 22, 2011
NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy
Gary R Hudes, Michael A Carducci, Toni K Choueiri, et al.
European Urology
|
April 18, 2017
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma
Sumanta K Pal, Guru Sonpavde, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 27, 2009
NCCN Task Force Report: Bone Health in Cancer Care
Julie R Gralow, J Sybil Biermann, Azeez Farooki, et al.
Page
of 16